The BIP Idea: Bronchiolocentric interstitial pneumonia defines ILD and fibrotic changes centered “along the airways,” Dr. Amita Sharma updated in her ARRS Quick Bytes video.
- Neither UIP, Nor NSIP: Unlike usual interstitial pneumonia or nonspecific interstitial pneumonia—which feature peripheral opacities—BIP presents with airway-focused abnormalities.
- Central fibrosis, ground-glass opacities, centrilobular nodules, and lobular lucency are all key findings.
Beyond HP, Too: Whereas Dr. Sharma does consider fibrotic hypersensitivity pneumonitis “the poster child” for bronchiolocentric involvement, BIP’s framework formalizes that non-HP causes can produce identical imaging features.
- Broader Etiologies: BIP encompasses changes driven by connective tissue diseases, drug-induced toxicity, and aspiration.
- IRL Dilemma: Patients presenting with a classic HP-like imaging pattern may actually have an underlying autoimmune condition (e.g., rheumatoid arthritis in Sharma’s case here).
Originally used primarily as a histologic descriptor, recent consensus statements bridge histopathologic findings of HP/BIP with high-res CT correlation—a trajectory similar to the introduction of idiopathic NSIP.
- Classification divides cases attributable to a known trigger or systemic disease (secondary BIP) and no identifiable cause (idiopathic BIP).
- Refinements clarify distinctions between secondary and idiopathic fibrotic vs. non-fibrotic alveolar and interstitial diseases.
Clinical Concern: Diagnosing a patient with ‘idiopathic BIP’ risks deterrence from searching for an environmental antigen, which remains the most crucial step in managing HP.
RadFYI: Work backward to firmly establish and validate the radiological-pathological correlation for bronchiolocentric interstitial pneumonia.

Leave a Reply